Q&A: Roche's Dan Chen Talks Immuno-Oncology Combinations

The head of Roche/Genentech's immuno-oncology programs sat down with the Pink Sheet at the recent American Society of Clinical Oncology annual meeting in Chicago.

More from Clinical Trials

More from R&D